Building on the pioneering work of its academic co-founders, including Charles Perou (co-inventor of the Prosigna breast cancer test), GeneCentric has become the leader in RNA bioinformatics ...

RNA oncology company TransCode Therapeutics has developed a modular, iron oxide nanoparticle–based nanocarrier system for the delivery of RNA therapeutics to tumors. The platform overcomes ...